JCB Chooses HPE GreenLake to Enhance Customer Experience and Modernize its Next Generation MyJCB Platform
Global payment brand and credit card company moves to a resilient, robust hybrid cloud environment…
News
Eyelit Announces Growth Investment from Banneker Partners
MISSISSAUGA, Ontario–(BUSINESS WIRE)–Eyelit Inc., a leader in Manufacturing Execution (MES), Quality Management (QMS), and Factory…
Granite Again Named Cradlepoint Partner of the Year
Company Excelling at Far More Than Just POTS QUINCY, Mass.–(BUSINESS WIRE)–Granite Telecommunications, a leader in…
Kymeta Signs Agreement with OneWeb to Distribute Low Earth Orbit Satellite Connectivity Services to Military, Government, and Commercial Customers
Kymeta’s electronically steered flat panel u8 terminal enables high-speed broadband connectivity while on the move…
New Model N Executive Report Places Technology as Central to Solving Revenue Management Issues in 2022
“2022 State Of Revenue Report” Shows Revenue Management Remains Susceptible to Changing Business Dynamics, Including…
Think outside the cell: Rows announces desktop apps beta launch and triple user growth following bold billboards outside Microsoft and Google HQs
Backed by Lakestar, Accel, and Cherry Ventures, the beta version of Rows’ app for Windows…
Speedcast Adds Software Path Certification from AWS to Its Cloud Qualifications, Bringing New Value to Customer Solutions
Technical validation of Speedcast SIGMA adds to the company’s credentials within the APN, including Advanced…
Maimonides Medical Center Adopts Revolutionary Technology That Quickly Distinguishes Bacterial and Viral Infections
Maimonides Medical Center Adopts Revolutionary Technology That Quickly Distinguishes Bacterial and Viral Infections Maimonides is…
Revelation Biosciences Inc. to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…
Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th
SOLANA BEACH, Calif., March 22, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a…
BioCorRx to Participate in Two Upcoming Conferences
ANAHEIM, CA, March 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat
WOBURN, Mass., March 22, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the…
AGTC Announces Pricing of Public Offering of Common Stock
GAINESVILLE, Fla., and CAMBRIDGE, Mass., March 22, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
POINT Biopharma Confirms No Delays to SPLASH Trial Due to Recent Global Lutetium Supply Interruption
POINT’s industry-leading radioisotope supply chain enabled company to avoid delays INDIANAPOLIS, March 22, 2022 (GLOBE…
Inactivating Mutations in Scaffold Component of PP2A, the Target Enzyme of LIXTE Biotechnology’s Clinical Compound LB-100, are Associated with Exceptionally Long Survival of Patients with Ovarian Clear Cell Cancer Treated with Immunotherapy
Outside research reports that immune checkpoint therapy of patients with ovarian clear cell carcinomas with…
Palisade Bio (Nasdaq: PALI) Receives FDA “Study May Proceed” Letter for Pivotal Phase 3 Clinical Trial Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery
CARLSBAD, Calif., March 22, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical…
CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results and Provide a Corporate Update on March 29
BERKELEY HEIGHTS, N.J., March 22, 2022 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
BrigHtn Phase 2 study with CIN-107 for Resistant Hypertension Enrollment Complete with Topline Results Expected…
Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial Results and Business Highlights
Completed Initial Public Offering in February 2022, Raising $16.0 million in Gross Proceeds Initiated Phase…
BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure
New Procedure Reimbursement Code Expected to Enhance Study Performance for Clinical Centers Participating in the…